- Global Pharma News & Resources

Anti-Epileptic Drugs Market 2019 Global Size, Growth, Regions, Type and Application, Status Forecast by 2019-2024

Market Research Engine has published a new report titled asAnti-Epileptic Drugs Market Size, By Drug (First Generation AEDs [Phenytoin, Carbamazepine, Oxycarbazepine, Valproate, Topiramate, Ethosuximide, Primidone, Phenobarbital], Second Generation AEDs [Lamotrigine, Pregabalin, Rufinamide, Levetiracetam, Ezogabine, Lacosamide, Eslicarbazepine Acetate, Zonisamide, Perampanel], Third Generation AEDs), By Distribution Channel (Retail Pharmacies, Hospitals Pharmacies, Drug-Store, Mail Order Pharmacies, E-commerce), By Region, Market Analysis Report, Forecast 2018-2024.”

Report scope:

The scope of the report includes a detailed study of anti-epileptic drugs market with the reasons given for variations in the growth of the industry in certain regions.

The top company reports are intended to provide our buyers with a snapshot of the industry’s most influential players.

The report covers a detailed competitive outlook including the market share and company profiles of the key participants operating in the global market. Key players profiled in the report include Pfizer Inc., Eisai Inc., GlaxoSmithKline PLC, UCB Biosciences Inc., Sanofi, Otsuka Pharmaceutical LTD., Sumitomo Dainippon Pharma Co., H. Lundbeck, and Shire PLC. Company profile includes assigning such as company overview, product landscape, financial overview, and recent developments.

Browse Full Report:

The anti-epileptic drugs market is segmented on the lines of its product, application, end-use and regional. The basis of drug the market is segmented into First Generation AEDs Second Generation AEDs, and Third Generation AEDs. Based on distribution channel the global anti-epileptic drugs market covers Retail Pharmacies, Hospitals pharmacies, Drug-store, Mail order pharmacies, and e-commerce. The anti-epileptic drugs market on geographic segmentation covers various regions such as North America, Europe, Asia Pacific, and Rest of World. Each geographic market is further segmented to provide market revenue for selected countries such as the U.S., Canada, Germany, UK, France, Italy, China, India, Japan, Brazil, South Africa and others.

Development of awareness programs will further improve the global anti-epileptic market revenue over the forecast time frame. Various organizations conducting these awareness programs include Epilepsy Association of Central Florida, Anita Kaufmann Foundation, Epilepsy Foundation, and CURE Epilepsy.

The global anti-epileptic drugs market is predicted to register exponential growth rate between 2018 and 2024 owing to upsurge in government funding for developing effective and new drugs for seizure treatment. For instance, American Epilepsy Society (AES) in partnership with other organizations such as Epilepsy Foundation, Academy of Neurology, and Grass Foundation offers funding for research.

Competitive Rivalry

Pfizer Inc., Eisai Inc., GlaxoSmithKline PLC, UCB Biosciences Inc., Sanofi, Otsuka Pharmaceutical LTD., Sumitomo Dainippon Pharma Co., H. Lundbeck, and Shire PLC are among the major players in the global anti-epileptic drugs market share. The companies are involved in several growth and expansion strategies to gain a competitive advantage. Industry participants also follow value chain integration with business operations in multiple stages of the value chain.

The Anti-Epileptic Drugs Market has been segmented as below:

Anti-Epileptic Drugs Market Research, By Drug

  • First Generation AEDs
    • Phenytoin, Carbamazepine
    • Oxycarbazepine
    • Valproate
    • Topiramate
    • Ethosuximide
    • Primidone
    • Phenobarbital
  • Second Generation AEDs
    • Lamotrigine
    • Pregabalin
    • Rufinamide
    • Levetiracetam
    • Ezogabine
    • Lacosamide
    • Eslicarbazepine Acetate
    • Zonisamide
    • Perampanel
  • Third Generation AEDs

Anti-Epileptic Drugs Market, By Distribution Channel

  • Retail Pharmacies
  • Hospitals pharmacies
  • Drug-store
  • Mail order pharmacies
  • E-commerce

Anti-Epileptic Drugs Market, By Region

  • North America
  • Europe
  • Asia Pacific
  • Rest of World

The report covers:

  • An overview of the global anti-epileptic drugs market and related technologies
  • Analyses of global market trends, with actual data for 2017, estimates for 2018, and projections of compound annual growth rates (CAGRs) through 2024
  • Identifications of new market opportunities and targeted promotional plans for anti-epileptic drugs market
  • Discussion of research and development, and the demand for new products and new applications.
  • Comprehensive company profiles of major players in the industry.

Reasons to Buy this Report:

  • Obtain the most up to date information available on the anti-epileptic drugs market
  • Identify growth segments and opportunities in the industry
  • Facilitate decision making on the basis of strong historic and forecast for anti-epileptic drugs market
  • Assess your competitor’s refining portfolio and its evolution

Request Sample Report from here:

Table of Contents:

  1.  Introduction
  2.  Research Methodology
  3.  Executive Summary
  4.  Market Overview
     4.1.    Introduction
        4.2.    Drivers
            4.2.1.    Presence of promising pipeline for epilepsy therapeutics
            4.2.2.    Need-gap for adequate seizure control
        4.3.    Restraints
            4.3.1.    High treatment cost
        4.4.    Opportunities
            4.4.1.    Advent of more adjunct therapies
        4.5.    Challenges
            4.5.1.    Competition from generic drugs
  5.  Anti-Epileptic Drugs Market, By Product
  6.  Anti-Epileptic Drugs Market, By Distribution Channel
  7.  Competitive Landscape
  8.  Company Profile
     8.1.    Pfizer Inc.
            8.1.1.    Company Overview
            8.1.2.    Product/Service Landscape
            8.1.3.    Financial Overview
            8.1.4.    Recent Developments
        8.2.    Eisai Inc
            8.2.1.    Company Overview
            8.2.2.    Product/Service Landscape
            8.2.3.    Financial Overview
            8.2.4.    Recent Developments
        8.3.    GlaxoSmithKline PLC
            8.3.1.    Company Overview
            8.3.2.    Product/Service Landscape
            8.3.3.    Financial Overview
            8.3.4.    Recent Developments
        8.4.    UCB Biosciences Inc.
            8.4.1.    Company Overview
            8.4.2.    Product/Service Landscape
            8.4.3.    Financial Overview
            8.4.4.    Recent Developments
        8.5.    Sanofi
            8.5.1.    Company Overview
            8.5.2.    Product/Service Landscape
            8.5.3.    Financial Overview
            8.5.4.    Recent Developments
        8.6.    Otsuka Pharmaceutical LTD.
            8.6.1.    Company Overview
            8.6.2.    Product/Service Landscape
            8.6.3.    Financial Overview
            8.6.4.    Recent Developments
        8.7.    Sumitomo Dainippon Pharma Co.
            8.7.1.    Company Overview
            8.7.2.    Product/Service Landscape
            8.7.3.    Financial Overview
            8.7.4.    Recent Developments
        8.8.    H. Lundbeck
            8.8.1.    Company Overview
            8.8.2.    Product/Service Landscape
            8.8.3.    Financial Overview
            8.8.4.    Recent Developments
        8.9.    Shire PLC
            8.9.1.    Company Overview
            8.9.2.    Product/Service Landscape
            8.9.3.    Financial Overview
            8.9.4.    Recent Developments

Media Contact

Company Name: Market Research Engine

Contact Person: John Bay


Phone: +1-855-984-1862

Country: United States


Editor Details

Related Links

Last Updated: 18-Jun-2019